BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
JPMorgan Reiterates Overweight Rating on BeiGene Ltd. (ONC), PT $311
March 3, 2025 4:19 PM ESTJPMorgan analyst Jessica Fye reiterated an Overweight rating and $311.00 price target on BeiGene Ltd. (NASDAQ: ONC)
The analyst comments "We hosted a call with mgmt and investors following ONCs strong 4Q print and 2025 guide. The conversation touched on the various factors associated with 2025... More
BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies
February 27, 2025 3:36 PM ESTJefferies analyst Kelly Shi raised the price target on BeiGene Ltd. (NASDAQ: ONC) to $308.00 (from $286.00) while maintaining a Buy rating.
The analyst comments "ONC posted strong FY results, with $3.8B FY rev (+55% YoY, vs $3.7B cons). Despite investor discussion of script discrepancies, Brukinsa... More
